The mds Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mds Hub cannot guarantee the accuracy of translated content. The mds and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Brought to you by Scientific Education Support

View all

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Create an account and access these new features:

Bookmark content to read later

Select your specific areas of interest

View mds content recommended for you

As of January 1st, 2024, the MDS Hub will no longer be updated. Please continue to browse our archive for valuable content. For the latest updates in MDS, visit our sister site aml-hub.com.

Our Hubs

SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide.

The hubs share new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage with treatment teams and researchers around the world, bringing the latest insights to healthcare professionals 24 hours per day, 7 days a week. Each hub is guided by an international steering committee of world-leading experts, who regularly meet to discuss the content and how to best address unmet educational needs.

Providing balanced, credible, and up-to-date medical education on all subtypes of lymphoma and chronic lymphocytic lymphoma (CLL), in partnership with the European Lymphoma Institute (ELI) and the European LeukemiaNet (ELN).

Providing balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML), in partnership with the European LeukemiaNet (ELN).

Providing balanced, credible, and up-to-date medical education on acute lymphoblastic leukemia (ALL), in partnership with the European School of Haematology (ESH).

Providing balanced, credible, and up-to-date medical education on acute and chronic graft-versus-host disease (GvHD), a common complication in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Working in partnership with the European LeukemiaNet (ELN) and the UK Photopheresis Society (UKPS).

Providing balanced, credible, and up-to-date medical education on lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN), in partnership with the Federation of Clinical Immunology Societies (FOCiS).

Providing balanced, credible, and up-to-date medical education on myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF), in partnership with the European LeukemiaNet (ELN).

Providing balanced, credible, and up-to-date medical education on multiple myeloma, in partnership with the European School of Haematology (ESH).

Providing balanced, credible, and up-to-date medical education on psoriasis and psoriatic arthritis, in partnership with the Federation of Clinical Immunology Societies (FOCiS).